Automated HPLC assay for urinary collagen cross-links: Effect of age, menopause, and metabolic bone diseases

Clinical Chemistry

Volumn 54, Issue 9, 2008, Pages 1546-1553

  Kraenzlin, Marius E ^a,b,d   Kraenzlin, Claude A ^b   Meier, Christian ^a,b   Giunta, Cecilia ^c   Steinmann, Beat ^c  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b Endocrine Practice and Laboratory   (Switzerland)

^c UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^d NONE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; DEOXYPYRIDINOLINE; PYRIDINOLINE;

ADULT; AGE; AGED; ARTICLE; BONE DENSITY; CONTROLLED STUDY; CROSS LINKING; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERPARATHYROIDISM; HYPERTHYROIDISM; MAJOR CLINICAL STUDY; MALE; MENOPAUSE; METABOLIC BONE DISEASE; OSTEOPOROSIS; PAGET BONE DISEASE; POSTMENOPAUSE; PREMENOPAUSE; REFERENCE VALUE; URINALYSIS;

ADULT; AGE DISTRIBUTION; BONE DISEASES, METABOLIC; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COLLAGEN; FEMALE; HEALTH; HUMANS; MALE; MENOPAUSE; MIDDLE AGED;

EID: 51349127339     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2008.105262     Document Type: Article

References (35)

1. Naylor KE, Eastell R. Measurement of biochemical markers of bone formation. In: Seibel M, Robins S, Bilezikian J, eds. Dynamics of bone and cartilage metabolism. Academic Press, 2006:529-40.
2. Kraenzlin ME, Seibel M. Measurement of biochemical markers of bone resorption. In: Seibel M, Robins S, Bilezikian J, eds. Dynamics in bone and cartilage metabolism. Academic Press 2006;541-64.
3. Woitge HW, Oberwittler H, Heichel S, Grauer A, Ziegler R, Seibel MJ. Short- and long-term effects of ibandronate treatment on bone turnover in Paget disease of bone. Clin Chem 2000;46:684-90.
4. Eyre D, Shao P, Weis MA, Steinmann B. The kyphoscoliotic type of Ehlers-Danlos syndrome (type VI): differential effects on the hydroxylation of lysine in collagens Iand II revealed by analysis of cross-liked telopeptides from urine. Mol Genet Metab 2002;76:211-16.
5. Steinmann B, Eyre DR, Shao P. Urinary pyridinoline cross-links in Ehlers-Danlos syndrome type VI. Am J Hum Genet 1995;57:1505-8.
6. Giunta C, Randolph A, Al-Gazali LI, Brunner HG, Kraenzlin ME, Steinmann B. Nevo syndrome is allelic to the kyphoscoliotic type of the Ehlers-Danlos syndrome (EDS VIA). Am J Med Genet A 2005;133:158-64.
7. Black D, Duncan A, Robins SP. Quantitative analysis of the pyrdinium crosslinks of collagen in urine using ion-paired reversed-phase high-performance liquid chromatography. Anal Biochem 1988;169:197-203.
8. Uebelhart D, Gineyts E, Chapuy MC, Delmas PD. Urinary excretion of pyridinium crosslinks: a new marker of bone resorption in metabolic bone disease. Bone Miner 1990;8:87-96.
9. Pratt DA, Daniloff YN, Duncan A, Robins SP. Automated analysis of the pyridinium crosslinks of collagen in tissue and urine using solid-phase extraction and reversed-phase high-performance liquid chromatography. Anal Biochem 1992;207:168-75.
10. Bank RA, Beekman B, Verzijl N, de Roos JA, Sakkee AN, TeKoppele JM. Sensitive fluorimetric quantitation of pyridinium and pentosidine crosslinks in biological samples in a single high-performance liquid chromatographic run. J Chromatogr B Biomed Sci Appl 1997;703:37-44.
11. Vesper HW, Audain C, Woolfitt A, Ospina M, Barr J, Robins SP, Myers GL. High-performance liquid chromatography method to analyze free and total urinary pyridinoline and deoxypyridinoline. Anal Biochem 2003;318:204-11.
12. Seibel MJ, Lang M, Geilenkeuser WJ. Interlaboratory variation of biochemical markers of bone turnover. Clin Chem 2001;47:1443-50.
13. Calabresi E, Lasagni L, Franceschelli F, Bartolini L, Serio M, Brandi ML. Use of an internal standard to measure pyridinoline and deoxypyridinoline in urine. Clin Chem 1994;40:336-7.
14. Jensen JB, Kollerup G, Sorensen A, Sorensen OH. Intraindividual variability of bone markers in the urine. Scand J Clin Lab Invest Suppl 1997;57:29-34.
15. Vesper HW, Smith SJ, Audain C, Myers GL. Comparison study of urinary pyridinoline and deoxypyridinoline. Clin Chem 2001;47:2029-31.
16. James IT, Perrett D. Automated on-line solid-phase extraction and high-performance liquid chromatographic analysis of total and free pyridinium crosslinks in serum. J Chromatogr A 1998;798:159-66.
17. Njeh CF, Apple K. Radiological assessment of a new bone densitometer-the Lunar EXPERT. Br J Radiol 1996;69:335-40.
18. Fatayerji D, Eastell R. Age-related changes in bone-turnover in men. J Bone Miner Res 1999;14:1203-10.
19. Robins SP. Cross-linking of collagen. Isolation, structural characterization and glycosylation of pyridinoline. Biochem J 1983;215:167-73.
20. Eyre DR, Paz MA, Gallop PM. Cross-linking in collagen and elastin. Ann Rev Biochem 1984;53:717-48.
21. Eyre DR. The specificity of collagen crosslinks as markers of bone and connective tissue degradation. Acta Orthop Scand 1995;66:166-70.
22. Colwell A, Russell RGG, Estell R. Factors affecting the assay of urinary 3-hydroxy pyridinium crosslinks of collagen as markers of bone resorption. Europ J Clin Invest 1993;23:341-9.
23. Robins SP, Stead DA, Duncan A. Precautions in using internal standard to measure pyridinoline and deoxypyrinoline in urine. Clin Chem 1994;40:2322-3.
24. Garnero P, Chapuy M-C, Marcelli C, Grandjean H, Muller C, Cormier C, et al. Markers of bone resorption predict hip fracture in elderly women: the EPIDOS prospective study. J Bone Miner Res 1996;11:1531-8.
25. Garnero P, Sornay-Rendu E, Claustrat B, Delmas PD. Biochemical markers of bone turnover, endogenous hormones and risk of fractures in postemenopausal women: the OFELY study. J Bone Miner Res 2000;15:1526-36.
26. Ross PD, Kress BC, Parson RE, Wasnich RD, Armour KA, Mizrahi IA. Serum bone alkaline phosphatase and calcaneus bone density predict fractures: a prospective study. Osteoporos Int 2000;11:76-82.
27. van Daele P, Seibel M, Burger H, Pols HA. Case-control analysis of bone resorption markers, disability and hip fracture: the Rotterdam study. Br Med J 1996;312:482-3.
28. Gerdhem P, Ivaska KK, Alatalo SL, Halleen JM, Hellman J, Isaksson A, et al. Biochemical markers of bone metabolism and prediction of fracture in elderly women. J Bone Miner Res 2004;19:386-93.
29. Bauer DC, Black DM, Garnero P, Hochberg M, Ott S, Orloff J, et al. Change in bone turnover and hip, non-spine, and vertebral fracture in alendronate-treated women: the fracture intervention trial. J Bone Miner Res 2004;19:1250-8.
30. Rauch F, Georg M, Stabrey A, Neu C, Blum WF, Remer T, et al. Collagen markers deoxypyridinoline and hydroxylysine glycosides: pediatric reference data and use for growth prediction in growth hormone-deficient children. Clin Chem 2002;48:315-22.
31. Schonau E, Rauch F. Markers of bone and collagen metabolism-problems and perspectives in paediatrics. Horm Res 1997;48 Suppl 5:50-9.
32. Bollen A-M, Eyre DR. Bone resorption rates in children monitored by the urinary assay of collagen type I cross-linked peptides. Bone 1994;15:31-4.
33. Szulc P, Seeman E, Delmas P. Biochemical measurements of bone turnover in children and adolescents. Osteoporos Int 2000;11:281-94.
34. Steinmann B, Royce PM, Superti-Furga A. The Ehlers-Danlos syndrome. In: Royce PM, Steinmann B, editors. Connective tissue and its heritable disorders: molecular, genetic, and medical aspects. 2nd ed. New York: Wiley-Liss; 2002:431-523.
35. Giunta C, Elçioglu NH, Albrecht B, Eich G, Chambaz C, Janecke AR, et al. Spondylocheiro dysplastic form of the Ehlers-Danlos syndrome: an autosomal recessive entity caused by mutations in the zinc transporter gene SLC39A13. Am J Hum Genet 2008;82:1290-305.